RxSight Inc (NASDAQ: RXST) on Monday, plunged -3.25% from the previous trading day, before settling in for the closing price of $8.0. Within the past 52 weeks, RXST’s price has moved between $6.32 and $58.23.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The company achieved an average annual earnings per share of -50.35%. With a float of $37.76 million, this company’s outstanding shares have now reached $40.59 million.
In an organization with 498 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 67.29%, operating margin of -23.27%, and the pretax margin is -16.72%.
RxSight Inc (RXST) Insider and Institutional Ownership
Observing investor behavior towards Medical Devices industry stocks is more important than anything else. The insider ownership of RxSight Inc is 7.08%, while institutional ownership is 92.02%. The most recent insider transaction that took place on Mar 12 ’25, was worth 180,002. In this transaction Director of this company sold 7,000 shares at a rate of $25.71, taking the stock ownership to the 24,793 shares. Before that another transaction happened on Mar 12 ’25, when Company’s Director proposed sale 7,000 for $25.71, making the entire transaction worth $180,002.
RxSight Inc (RXST) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around -50.35% per share during the next fiscal year.
RxSight Inc (NASDAQ: RXST) Trading Performance Indicators
RxSight Inc (RXST) is currently performing well based on its current performance indicators. A quick ratio of 11.65 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2.12.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.67, a number that is poised to hit -0.24 in the next quarter and is forecasted to reach -1.01 in one year’s time.
Technical Analysis of RxSight Inc (RXST)
Let’s dig in a bit further. During the last 5-days, its volume was 5.35 million. That was better than the volume of 1.01 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 23.83%.
During the past 100 days, RxSight Inc’s (RXST) raw stochastic average was set at 5.70%, which indicates a significant decrease from 17.91% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.76 in the past 14 days, which was lower than the 0.99 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $13.89, while its 200-day Moving Average is $29.71. However, in the short run, RxSight Inc’s stock first resistance to watch stands at $8.01. Second resistance stands at $8.29. The third major resistance level sits at $8.45. If the price goes on to break the first support level at $7.58, it is likely to go to the next support level at $7.42. The third support level lies at $7.14 if the price breaches the second support level.
RxSight Inc (NASDAQ: RXST) Key Stats
Market capitalization of the company is 314.53 million based on 40,637K outstanding shares. Right now, sales total 139,930 K and income totals -27,460 K. The company made 37,900 K in profit during its latest quarter, and -8,190 K in sales during its previous quarter.
